WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹8,138 Cr | ₹7,586 Cr | ₹7,070 Cr | ₹7,075 Cr | ₹7,670 Cr |
What is the latest Total Liabilities ratio of WOCKHARDT ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹8,138 Cr |
| Mar2025 | ₹7,586 Cr |
| Mar2024 | ₹7,070 Cr |
| Mar2023 | ₹7,075 Cr |
| Mar2022 | ₹7,670 Cr |
How is Total Liabilities of WOCKHARDT Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹8,138 Cr | 7.28 | |
| Mar2025 | ₹7,586 Cr | 7.30 | |
| Mar2024 | ₹7,070 Cr | -0.07 | |
| Mar2023 | ₹7,075 Cr | -7.76 | |
| Mar2022 | ₹7,670 Cr | - | |
Compare Total Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹30,979.8 Cr | -3.7% | -7.9% | 40.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,684.0 Cr | -1.4% | -6.5% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,311.0 Cr | -2% | -2.7% | 40.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,079.0 Cr | -1.8% | -7% | 29.6% | Stock Analytics | |
| CIPLA | ₹107,528.0 Cr | 0.1% | -3% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,667.0 Cr | 0.2% | 6% | -2.4% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -3.7% |
-7.9% |
40.4% |
| SENSEX | 2.7% |
-0.7% |
-10.5% |
You may also like the below Video Courses